In addition to identification of plasma EV CD59 and TSPAN9 as a two-marker panel for CRC detection, the pathobiological roles of EV CD59 and TSPAN9 in the tumor microenvironment and/or chemoresistance of CRC obviously remain as intriguing issues that warrant further investigation. Here, TSPAN9 is linked to colorectal carcinoma.